Herbert Loong, Advisor at Greater Bay Area International Clinical Trial Institute, and Steering Committee Member at Lung Cancer Policy Network, shared a post on X:
“A monumentous project starting to bear fruit!
The Hong Kong Genome Project has just published report findings from 20,000 participants across Rare Diseases and suspected Genetic Diseases cohorts in Nature Medicine.
We aim to curate a Hong Kong Chinese reference for clinically relevant Genetic Variations.”
Title: Population-scale genomic medicine with the Hong Kong Genome Project
Authors: Dingge Ying, Ching-Lung Cheung, Chun-Kwan O, Wai Kei Jacky Lam, Shiu Lun Au Yeung, Chak Sing Lau, Ho Ming Luk, Christopher Kai Shun Leung, Desiree Man Sik Tse, James Si Chai Liu, Shirley Pik Ying Hue, Jamie Sui Lam Kwok, Denis Long Him Yeung, Christopher Brandon Preusch, Wei Ma, Wenshu Tang, Amy Hin Yan Tong, Lisa Wing Chi Au, Juliana Chung-Ngor Chan, Yap-Hang Chan, Shirley Sze Wing Cheng, Shuk Ching Chong, Cheuk Wing Fung, Stephanie Ho, Suhas Krishnamoorthy, Gabriel Matthew Leung, Philip Hei Li, Qing Li, Herbert Ho-Fung Loong, Rashid Nok Shun Lui, Shan Luo, Becky Mingyao Ma, Ronald Ching Wan Ma, Rong Na, Kathryn Choon Beng Tan, Sheila Suet-Na Wong, Su-Vui Lo, Hong Kong Genome Project, Annie Tsz Wai Chu, Brian Hon Yin Chung
Other articles featuring Herbert Loong on OncoDaily.
